Skip to content

Preventing and managing heart failure

According to the Global Health Data Exchange registry, there were 64.3 million cases of heart failure in 2020, and rising rapidly. The need to detect and diagnose heart failure more efficiently has never been more urgent. Ultromics' AI can improve outcomes by identifying indicators as soon as possible.

Using echocardiography to diagnose heart failure

Echocardiography plays a central role in diagnosing heart failure.  The 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure recommended the use of both LV ejection fraction (LVEF) and global longitudinal strain (GLS) to diagnose heart failure.

It's estimated that 50% of patients have preserved ejection fraction (HFpEF).  However, ejection fraction (LVEF) by echocardiography often fails to detect small changes.

It is global longitudinal strain (GLS) that completes the analysis.

Download the guide to improved Heart Failure detection

What can be done to better manage heart failure

EchoGo provides rapid interpretation of echocardiograms on over 230+ measurements, including the most widely used metrics to help identify heart failure, including LV ejection fraction, strain and volumes.

It can detect heart failure with preserved ejection fraction (HFpEF) by using AI and echo strain. GLS is the optimal parameter of deformation for the early detection of subclinical LV dysfunction.

EchoGo Core: Automated LV analysis

We calculate the most common measurements helpful in the diagnoses of heart health, including Global Longitudinal Strain (GLS), Ejection Fraction (EF), Left ventricle end-diastolic volume (LV EDV), Left ventricle end-systolic volume (LV ESV), Left ventricle end-diastolic length (LVL ED), Left ventricle end-systolic length (LVL ES) – from 4C, A2C, A4C/A2C, A3C, A4C/A2C/A3C views and Biplane.

Precise

Zero variability between operators.

Fast

Save up to 25% of study time.

Predictive

Clinically validated to outperform manual analysis.

See the features and capabilities of EchoGo Core

Validated in clinical settings

Our technology is validated in real-world clinical settings and research publications.

  • A JACC Imaging publication shows EchoGo increased sensitivity on stress echo reads by 10%.

  • A study in JASE with MedStar shows EchoGo minimized operator variability and improved the accuracy in outcome prediction compared to manual reads.
See the peer-reviewed evidence

Dr Patricia A. Pellikka from Mayo Clinic presents using EchoGo to detect heart failure

Dr. Patricia Pellikka from Mayo Clinic discusses the utilization of Ultromics' deep-learning echocardiography applications for the diagnostic classification of cardiovascular disease, clinically validated to be superior than traditional manual analysis.

 

 

"We are pleased to collaborate with Ultromics to help increase the diagnostic accuracy of detection of cardiovascular diseases with echocardiography."

Dr Patricia A. Pellikka,

Vice Chair, Department of Cardiovascular Medicine at Mayo Clinic.

Discover how you can integrate AI in your workflow to diagnose heart failure

Download the guide to improved Heart Failure detection Contact us